Clinical Drug Experience Knowledgebase

Aggression (Phase 3)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Cholera (Phase 4)

Communicable Diseases (Phase 3)

Coronavirus Infections (Phase 3)

Deficiency Diseases (Phase 4)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Diarrhea (Phase 3)

Dysentery (Phase 2)

Filariasis (Phase 4)

Gastroenteritis (Phase 3)

Graft vs Host Disease (Phase 2)

Helminthiasis (Phase 4)

Hemophilia A (Phase 2)

Hemophilia B (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hypertension (Phase 4)

Infections (Phase 3)

Leukemia (Phase 3)

Leukemia, Promyelocytic, Acute (Phase 3)

Mental Disorders (Phase 3)

Multiple Myeloma (Phase 2)

Mycobacterium Infections (Phase 2)

Myopia (Phase 1)

Myopia, Degenerative (Phase 1)

Neoplasms, Plasma Cell (Phase 2)

Osteogenesis Imperfecta (Phase 2)

Poliomyelitis (Phase 4)

Prostatic Neoplasms (Phase 2)

Psychotic Disorders (Phase 3)

Pyelonephritis (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Surgical Wound Infection (Phase 3)

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Urinary Tract Infections (Phase 3)

Vibrio Infections (Phase 2)